Pneumococcal pneumonia and influenza: a deadly combination

Area of Science:

• Public Health
• Infectious Diseases
• Vaccinology

Background:

• Pneumococcal co-infection significantly increases morbidity during viral respiratory infections.
• Pneumonia remains a leading cause of childhood mortality globally.
• The 1918 influenza pandemic highlights the deadly impact of bacterial co-infections, particularly pneumococcus.

Purpose of the Study:

• To assess the impact of pneumococcal conjugate vaccines (PCV) on pneumonia incidence and influenza hospitalizations in children.
• To evaluate the role of pneumococcal vaccination in pandemic influenza preparedness.

Main Methods:

• Analysis of clinical pneumonia incidence data in the United States before and after PCV introduction.
• Review of hospitalization data associated with influenza in children.
• Historical analysis of mortality data from the 1918 influenza pandemic.

Main Results:

• Introduction of PCV in the US correlated with a 39% decrease in clinical pneumonia incidence among children.
• PCVs have demonstrated a reduction in influenza-associated hospitalizations in pediatric populations.
• Bacterial infections, primarily pneumococcus, were the main drivers of mortality during the 1918 influenza pandemic.

Conclusions:

• Pneumococcal vaccination is highly effective in reducing childhood pneumonia and influenza-related hospitalizations.
• Widespread pneumococcal vaccination (PCV for children, PPSV for adults) is a critical component of pandemic influenza preparedness.
• Preventing pneumococcal co-infections is essential for mitigating severe outcomes of viral respiratory infections.